Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
119.95
0.00 (0.00%)
At close: Mar 4, 2026
42.80%
Market Cap 438.05B
Revenue (ttm) 263.07B
Net Income (ttm) 42.47B
Shares Out 3.65B
EPS (ttm) 11.63
PE Ratio 10.31
Forward PE n/a
Dividend 14.20 (11.84%)
Ex-Dividend Date Feb 24, 2026
Volume n/a
Average Volume 16,226
Open n/a
Previous Close 119.95
Day's Range n/a
52-Week Range 73.01 - 121.00
Beta -0.12
RSI 74.64
Earnings Date Feb 9, 2026

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In fiscal year 2025, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements

News

There is no news available yet.